Abstract-Pharmaceuticals and personal care products are being increasingly reported in a variety of biological matrices, including fish tissue; however, screening studies have presently not encompassed broad geographical areas. A national pilot study was initiated in the United States to assess the accumulation of pharmaceuticals and personal care products in fish sampled from five effluent-dominated rivers that receive direct discharge from wastewater treatment facilities in Chicago, Illinois; Dallas, Texas; Orlando, Florida; Phoenix, Arizona; and West Chester, Pennsylvania, USA. Fish were also collected from the Gila River, New Mexico, USA, as a reference condition expected to be minimally impacted by anthropogenic influence. High performance liquid chromatography-tandem mass spectrometry analysis of pharmaceuticals revealed the presence of norfluoxetine, sertraline, diphenhydramine, diltiazem, and carbamazepine at nanogram-per-gram concentrations in fillet composites from effluent-dominated sampling locations; the additional presence of fluoxetine and gemfibrozil was confirmed in liver tissue. Sertraline was detected at concentrations as high as 19 and 545 ng/ g in fillet and liver tissue, respectively. Gas chromatography-tandem mass spectrometry analysis of personal care products in fillet composites revealed the presence of galaxolide and tonalide at maximum concentrations of 2,100 and 290 ng/g, respectively, and trace levels of triclosan. In general, more pharmaceuticals were detected at higher concentrations and with greater frequency in liver than in fillet tissues. Higher lipid content in liver tissue could not account for this discrepancy as no significant positive correlations were found between accumulated pharmaceutical concentrations and lipid content for either tissue type from any sampling site. In contrast, accumulation of the personal care products galaxolide and tonalide was significantly related to lipid content. Results suggest that the detection of pharmaceuticals and personal care products was dependent on the degree of wastewater treatment employed.

A liquid chromatography-tandem mass spectrometry (LC-MS/MS) screening method has been developed targeting 23 pharmaceuticals and 2 metabolites with differing physicochemical properties in fish tissue. Reversed-phase separation of target compounds was achieved using a C18 column and a nonlinear gradient consisting of 0.1% (v/v) formic acid and methanol. Eluted analytes were introduced into the mass analyzer using positive or negative electrospray ionization, as appropriate. A variety of extraction solvents, differing in polarity, pH, or both, were investigated in order to assess recovery of target compounds from 1-g tissue homogenates. Among 10 solvents tested, a 1:1 mixture of 0.1 M aqueous acetic acid (pH 4) and methanol was identified as optimal, resulting in extraction recoveries for 24 of 25 compounds exceeding 60%. Tissue extracts were found to influence the LC-MS/MS response for several analytes. Consequently, matrix-matched calibration standards were employed to determine analyte concentrations in environmental samples. Statistically derived method detection limits were <6 ng/g for most analytes. The method was subsequently used to screen for target analytes in fish from an effluent-dominated stream. Diphenhydramine, diltiazem, carbamazepine, and norfluoxetine were detected in 11 of 11 environmental samples at concentrations ranging from 0.11 to 5.14 ng/g.The occurrence of pharmaceuticals and personal care products (PPCPs) in the environment has received broad interest over the past decade. 1-4 PPCPs have been increasingly detected in water, wastewater, soil, sediments, and biosolids. More recently, reports from our laboratory 5 and others 6-10 have demonstrated that environmental exposures to PPCPs may result in accumulation of parent compounds, their metabolites, or both in tissues of aquatic organisms. These reports have heightened interest in secondary effects of PPCPs and impart a sense of urgency to research focused on understanding fate and partitioning of these compounds in aquatic systems.Analytical protocols for determination of PPCPs in water, sediment, and biosolids are numerous and have been summarized in recent reviews. [11][12][13][14] Due to the complexity of environmental samples, analyses typically employ detailed sample preparation followed by chromatographic separation of analytes and mass spectrometry detection. While methods focused on a single compound or unique compound class (e.g., antibiotics) continue to be reported, [15][16][17][18][19][20] increasing emphasis on simultaneous analysis of compounds with dissimilar physicochemical properties is evident in recent literature. 11,[21][22][23][24][25] This shift in philosophy stems from a desire to gain diverse knowledge with minimum analytical expenditure.

One of the hallmarks of ionic liquids (ILs) and a critical part of their sustainable implementation is their low volatility, although statements in this regard are frequently made in the absence of a critical evaluation. Although it is generally accepted that conventional ILs exhibit significantly reduced vapor pressures relative to common organic solvents, glib statements about ILs having zero volatility can no longer be abided, even if a concrete temperature-dependent vapor pressure, Pvap(T), framework for placement of IL performance has not yet been established. In this communication, Pvap(T) values of 30 illustrative low-volatility fluids—including representative imidazolium-, ammonium-, and pyrrolidinium-based aprotic ILs; examples of protic, polymeric, and di-cationic ILs; as well as deep eutectic solvents (DESs) and glycols—were determined using a simple, convenient, and reproducible isothermal thermogravimetric method. Guided by this “vapor pressure map”, observed trends can be discussed in terms of anion basicity, cation geometry, alkane chain length, hydrogen bonding strength, and van der Waals forces, providing a context for the placement of theoretical and experimental vapor pressures gleaned in future IL and DES studies.

Propranolol is a widely prescribed, nonselective beta-adrenergic receptor-blocking agent. Propranolol has been detected in municipal effluents from the ng/L to the low-microg/L range. Like many therapeutics and other aquatic contaminants, propranolol is distributed as a racemic mixture ((R,S)-propranolol hydrochloride). Although the (S)-enantiomer is the most active form in mammals (up to 100-fold difference), no information is available regarding the enantiospecific toxicity of propranolol to aquatic organisms. Acute and chronic studies were conducted with Daphnia magna and Pimephales promelas to determine enantiospecific toxicity of propranolol to a model aquatic invertebrate and vertebrate, respectively. Also, enantiospecific effects of propranolol on D. magna heart rate were examined. Propranolol treatment levels were verified using high-performance liquid chromatography/mass spectrometry. Acute (48-h) responses of both organisms were similar for all enantiomer treatments. Chronic P. promelas responses to propranolol enantiomers followed the hypothesized relationship of (S)-propranolol being more toxic than (R)-propranolol, but chronic D. magna responses did not. This is potentially the result of a lack of beta-type receptors in cladocerans. No enantiospecific effects on daphnid heart rate were observed in acute exposures. Interestingly, some propranolol enantiomer treatments produced significant increases in reproduction before causing reproduction to decrease at higher treatment levels. To our knowledge, this research represents the first study of enantiospecific toxicity of chiral pharmaceutical pollutants.